AzurRx (AZRX) Corporate Media Kit

34 V2 (Baseline) AVG V4-V6 Change CFA (%) 78.4 87.4 9 CNA (%) 96.6 97.7* 1.1 Stool Weight (g/72h) 784.2 552.7 -231.5 Stools/Day 6.8 4.8 -2.0 Steatorrhea (g/24h) 21.0 12.6 -8.5 Interim Data from the First Five Patients in Combination Study Primary and Secondary Efficacy Endpoints Met * CNA data not available for one patient on V5 and one patient on V6.